Casting away burn stiffness: a new hope for arm movement?

NCT ID NCT05425433

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether serial casting (applying a cast that is changed weekly) can improve arm and hand movement in adults who have stiff joints from burn scars. Twelve burn survivors with limited range of motion received one week of usual care, then serial casting if needed. Researchers measured joint movement, scar quality, and how well people could use their arm, checking if improvements lasted three weeks after stopping casting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Sep 2022

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Burn survivors with \>15% loss of PROM of their PIP, MCP, wrist, or elbow in either: flexion, extension, ulnar deviation or radial deviation. * Fire, flame or scald burn injury -≥16 years old * have provided informed consent. Exclusion Criteria: * Frostbite, chemical or electrical burn injury * A premorbid musculoskeletal or neurological disorder that limited their ROM * Have sustained a neurological injury secondary to the burn injury * A psychiatric or cognitive disorder that limits their ability to follow the research protocol * Have been diagnosed with heterotopic ossification * PROM is contraindicated for any reason * Do not understand English or French.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Burn contracture of skin are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital de réadaptation Villa Médica

    Montreal, Quebec, H2X 1C9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.